Teladoc Health Reports Third-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Teladoc (TDOC) Tops Q3 EPS by 12c, Offers Q3 Guidance
October 26, 2022 4:11 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $611.4 million versus the consensus estimate of $608.76 million.
GUIDANCE:
Teladoc sees Q4 2022 EPS of ($0.40)-($0.10), versus the consensus of ($0.26). Teladoc sees Q4... More



